
Buprigesic 5mg Transdermal Patch
Marketer
Neon Laboratories Ltd
Salt Composition
Buprenorphine (5mg)
Overview Buprigesic 5mg Transdermal Patch
Buprenorphine 5mg transdermal patches manage moderate to severe pain and opioid addiction, mitigating withdrawal symptoms. Administering this medication requires precise adherence to your physician's instructions for optimal results. Dosage and treatment length vary depending on your condition and response. Consistent use is crucial; cessation should only occur under medical supervision. Common side effects, such as nausea, constipation, headache, dizziness, and drowsiness, may be more prevalent initially or following dosage adjustments, typically subsiding with continued use. Severe or persistent side effects necessitate patch removal and immediate medical attention. Inform your doctor of all pre-existing health conditions and medications before starting treatment, as interactions are possible. Pregnant or breastfeeding individuals must seek medical counsel prior to use.
Uses of Buprigesic 5mg Transdermal Patch
Morphine addiction; Management of significant to intense pain
Major Benefits of Buprigesic 5mg Transdermal Patch:
Follow your doctor's instructions precisely regarding dosage and treatment length. Always verify the product information before application. Ensure the application area is clean and completely dry. Peel away the patch's protective backing. Avoid contact with the adhesive surface. Apply the patch firmly to the skin with the adhesive side facing down, ensuring even contact.
Common Side effects of Buprigesic 5mg Transdermal Patch:
- Headache
- Back pain
- Drowsiness
- Vomiting
- Insomnia (difficulty in sleeping)
- Dizziness
- Abdominal pain
- Weakness
- Sweating
- Constipation
- Withdrawal syndrome
- Infection
- Vertigo
- Inflammation of the nose
- Chills
- Flu-like symptoms
- Nausea
How to use Buprigesic 5mg Transdermal Patch:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and schedule. Always verify the product label prior to application. Ensure the application area is clean and completely dry. Peel away the patch's protective covering, avoiding contact with the adhesive surface. Apply the patch to the skin with the adhesive side facing down, ensuring even contact.
How Buprigesic 5mg Transdermal Patch works:
The transdermal Buprigesic 5mg patch utilizes a partial opioid agonist mechanism. It mitigates opioid withdrawal by mimicking the actions of opioid medications. Furthermore, it alleviates pain by interacting with specialized brain receptors, thus modifying pain perception and response.
SAFETY ADVICE
AlcoholNone
No known drug interactions.
PregnancyCONSULT YOUR DOCTOR
The use of Buprigesic 5mg Transdermal Patches during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Medical advice is recommended.
Breast feedingCONSULT YOUR DOCTOR
The transdermal Buprigesic 5mg patch is likely not safe for use while breastfeeding. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingNone
No known drug interactions.
KidneyCAUTION
The transdermal Buprigesic 5mg patch requires careful administration for individuals with advanced renal impairment. Dosage modification of the Buprigesic 5mg transdermal patch might be necessary. Physician consultation is advised.
LiverCAUTION
The transdermal Buprigesic 5mg patch requires careful administration in individuals with advanced liver disease. Dosage modification of the Buprigesic 5mg patch may be necessary. Physician consultation is recommended. An alternative pain reliever offering greater dosing flexibility should be considered for patients exhibiting significant hepatic dysfunction.
What if you forget to take Buprigesic 5mg Transdermal Patch :
NA
Facts to Know About Buprigesic 5mg Transdermal Patch
| Label | Value |
|---|---|
| Chemical Category | Phenanthrene Derivatives |
| Developing Habits | . |
| Treatment Category | Neuroscience of the Central Nervous System |
